Orphan designation: Marzeptacog alfa (activated), Treatment of haemophilia B, 01/04/2019, Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 3 August 2023 - 15:37

Orphan designation: Marzeptacog alfa (activated), Treatment of haemophilia B, 01/04/2019, Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-19-2151

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters